Health IT

Latest Mobile MIM radiology app gets Canadian regulatory approval

Health IT firm MIM Software has obtained Canadian regulatory approval to begin marketing version 3.0 of its Mobile MIM radiology app for the iPhone, iPad and iPod Touch. The app is now cleared in Canada for diagnostic X-ray and ultrasound viewing, as well as radiation oncology treatment plan review and approval, according to a statement […]

Health IT firm MIM Software has obtained Canadian regulatory approval to begin marketing version 3.0 of its Mobile MIM radiology app for the iPhone, iPad and iPod Touch.

The app is now cleared in Canada for diagnostic X-ray and ultrasound viewing, as well as radiation oncology treatment plan review and approval, according to a statement from Cleveland-area MIM Software.

Sponsored Post

Physician Targeting Using Real-time Data: How PurpleLab’s Alerts Can Help

By leveraging real-time data that offers unprecedented insights into physician behavior and patient outcomes, companies can gain a competitive advantage with prescribers. PurpleLab®, a healthcare analytics platform with one of the largest medical and pharmaceutical claims databases in the United States, recently announced the launch of Alerts which translates complex information into actionable insights, empowering companies to identify the right physicians to target, determine the most effective marketing strategies and ultimately improve patient care.

Mobile MIM version 3.0, which is available for free download from Apple’s App Store, received clearance by the U.S. Food and Drug Administration last month.

About a year ago, an earlier version of Mobile MIM became the first-ever radiology mobile app to receive the FDA’s seal of approval.

Below, MIM Software chief technology officer Mark Cain provides a tour of Mobile MIM 3.0.